Name : Mouse CXCL13/BCA-1 Protein
Product Source :
Recombinant Mouse CXCL13/BCA-1 Protein is expressed from HEK293 with hFc tag at the N-Terminus. It contains Ile22-Ala109.[Accession | O55038]
Molecular Weight :
The protein has a predicted MW of 37.1 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Tris-Bis PAGE result.
Endotoxin Level :
Less than 1EU per μg by the LAL method.
Purity :
> 95% as determined by Tris-Bis PAGE> 95% as determined by HPLC
Formulation :
Supplied as 0.22μm filtered solution in 50mM Tris, 500mM NaCl (pH 7.5).
Reconstitution :
Storage and Stability :
Valid for 12 months from date of receipt when stored at -80°C. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Product Concentration :
Tris-Bis PAGE Mouse CXCL13 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%. SEC-HPLC The purity of Mouse CXCL13 is greater than 95% as determined by SEC-HPLC.
Background :
Recent studies have implicated chemokines in microglial activation and pathogenesis of neuropathic pain. C-X-C motif chemokine 13 (CXCL13) is a B lymphocyte chemoattractant that activates CXCR5. Using the spinal nerve ligation (SNL) model of neuropathic pain, CXCL13 was persistently upregulated in spinal cord neurons after SNL, resulting in spinal astrocyte activation via CXCR5 in mice.
Synonyms :
ANGIE; ANGIE2; BCA-1; BCA1; BLC; BLR1L; SCYB13
References & Citations :
(1) Jiang BC, Cao DL, Zhang X, Zhang ZJ, He LN, Li CH, Zhang WW, Wu XB, Berta T, Ji RR, Gao YJ. CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5. J Clin Invest. 2016 Feb;126(2):745-61. doi: 10.1172/JCI81950. Epub 2016 Jan 11. PMID: 26752644; PMCID: PMC4731172.
Related category websites: https://www.medchemexpress.com/recombinant-proteins.html
Popular product recommendations:
P4HB Proteinmedchemexpress
Cathepsin B ProteinStorage & Stability
Popular categories:
CD85a/ILT-5
Fibroblast Growth Factor 21 (FGF-21)